Personalized, adaptive deep brain stimulation (DBS) can enhance the control of motor symptoms of Parkinson's disease (PD) compared with standard DBS, new research suggests. In a blinded randomized ...

Adaptive deep-brain stimulation (DBS) using personalized neural signals improved Parkinson's motor symptoms in a pilot study. Adaptive DBS reduced the duration of symptoms by about 50% compared with ...

Adaptive DBS with fully embedded control. Top panel: time domain signal recorded from motor cortex; second panel: classifier state (gold), DBS voltage (blue) and gamma power (red). Scientists in the ...

At 40, Keith Krehbiel was a successful political scientist with a distinguished professorship, an award-winning book and a membership at the American Academy of Arts and Sciences. But he also was ...

In a small study, researchers funded by the National Institutes of Health captured more than 1,000 hours of brain recordings from patients with OCD in the clinic and at home. These data are a key ...

Deep brain stimulation (DBS) is often used in refractory cases of Parkinson’s disease as well as in a number of other movement disorders. Electrodes are placed in deep nuclei of the brain, and ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...

Medtronic plc’s Brainsense adaptive deep brain stimulation system has been shown to be tolerable, effective and safe for long-term use at home in people with Parkinson’s disease. A study published in ...

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...